VGLL4 was downregulated in CRC, with its expression level being inversely correlated with those of Wnt/β-catenin and Hippo-YAP target genes, indicating that VGLL4 acts as a tumour suppressor in CRC by co-regulating both signalling pathways. The gene discussed is VGLL4; the disease is neoplasm.